The Column Group II, LP 13D and 13G filings for eFFECTOR Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-22 4:16 pm Sale | 2023-11-15 | 13D | eFFECTOR Therapeutics, Inc. EFTR | The Column Group II, LP | 0 0.000% | -163,669 (Position Closed) | Filing |
| 2023-09-15 4:05 pm Sale | 2023-06-15 | 13D | eFFECTOR Therapeutics, Inc. EFTR | The Column Group II, LP | 163,669 6.600% | -8,704 (-5.05%) | Filing |
| 2021-09-07 5:12 pm Purchase | 2021-08-25 | 13D | eFFECTOR Therapeutics, Inc. EFTR | The Column Group II, LP | 172,373 10.600% | 172,373 (New Position) | Filing |